Molecular diagnostics is a powerful player in healthcare today. Technological advances and personalized medicine are driving rapid growth, and the healthcare industry is demanding more accurate diagnosis and treatment of disease. This transformation promises benefits for patient, healthcare, and industry alike. New tests and systems must truly demonstrate clinical value and validity in order to achieve widespread adoption. The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Trends in Cancer Diagnostics, Molecular Diagnostics for Infectious Disease, and Co-Development of Drugs and Diagnostics) is designed to bring together all of the major players in the Molecular Diagnostics arena. We have assembled an impressive faculty of speakers from industry, government, and the leading academic institutions. This meeting will showcase advances in technology, research and diagnostic development with an emphasis towards application to meet the demands of the clinic.